Clinical Trial

A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions

Study acronym: ML-HNC-Risk
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to develop and validate a clinical prediction model for the risk of head and neck cancerous lesions using deep learning combined with AI algorithms, based on multi-center clinical data.
Trial Details
NCT Number NCT07532538
Lead Sponsor The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborators: Taikang Xianlin Drum Tower Hospital, Zhongda Hospital, Affiliated Cixi Hospital of Wenzhou Medical University, Changzhou Fourth People's Hospital, Nanjing Tongren Hospital, Nanjing Children's Hospital, Gansu Provincial Maternal and Child Health Care Hospital, Shanghai Putuo District People's Hospital, Wuxi Huishan District People's Hospital, Fengyang County Hospital of Traditional Chinese Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Conditions Hypopharyngeal Cancer, Laryngeal Cancer, Head and Neck Cancer
Enrollment 3,000 participants
Start Date 2026-04-30
Primary Completion 2029-11-30 (estimated)
Study Completion 2030-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-16